Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2024 | The future of CAR-T for hematological malignancies and solid tumors

Alex Rampotas • 15 Feb 2024
CAR-T Meeting 2024
General CAR-T

In this video, Alex Rampotas, MD, University College London, London, UK, briefly discusses how the rise of CAR T-cell therapy may change the field of hematological oncology. Dr Rampotas also hopes this revolutionary treatment option will exhibit positive results when tested in solid tumors. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Conference fees: Gilead.

More from Alex Rampotas

2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
1:15
Comparing the efficacy of salvage therapies in adult B-ALL: a retrospective real-world study
Alex Rampotas • 16 Apr 2024
1:07
The real-world efficacy of CAR-T cells in post-transplant relapsed B-ALL
Alex Rampotas • 15 Feb 2024
1:06
How will novel agents & CAR-T cells affect the future treatment landscape in B-ALL?
Alex Rampotas • 15 Feb 2024

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals